How to Help Your Patients Save Money on Seysara: A Provider's Guide to Savings Programs

Seysara (sarecycline) is an FDA-approved, narrow-spectrum tetracycline antibiotic for moderate to severe acne with a robust clinical profile. But its retail price of over $1,100 per month — and inconsistent insurance coverage — create real access barriers that prevent many patients from benefiting from it. As a prescriber, understanding the savings landscape for Seysara allows you to proactively address cost barriers at the point of care, reducing prescription abandonment and treatment gaps.

Understanding the Cost Barrier: Why Seysara Is Expensive

Seysara is a brand-only drug with no generic equivalent as of 2026. The American Academy of Dermatology conditionally recommends Seysara for acne — acknowledging its clinical advantages over older tetracyclines while noting that cost may limit equitable access. As a prescriber, you're likely already aware that many patients filled with Seysara don't refill it:

High retail price ($1,100–$1,325/month) creates sticker shock at the pharmacy counter

Many commercial plans require prior authorization or don't include Seysara on formulary

Medicare and Medicaid beneficiaries cannot use the manufacturer's copay card

Pharmacy stocking issues add another layer of friction to an already complicated access process

Savings Tool 1: The Almirall Advantage Copay Card Program

The Almirall Advantage Seysara Savings Program is the most impactful cost-reduction tool for eligible patients:

Commercially insured patients: Copay as low as $35 per prescription (maximum reimbursement limits apply)

Commercially insured without drug coverage: No more than $75/prescription in-network, or $175 out-of-network

Enrollment: Text SEYSARA to 39107 or visit almiralladvantage.com

Exclusions: NOT available for Medicare, Medicaid, Tricare, CHIP, VA/DoD, Indian Health Service, or any federal/state government-funded health program

Best practice: Add Almirall Advantage information to your standard Seysara prescribing workflow. Consider keeping the enrollment information in your EHR's medication note template so it's automatically included whenever Seysara is prescribed.

Savings Tool 2: GoodRx and Third-Party Discount Programs

For patients who are not eligible for the manufacturer copay card (including Medicare beneficiaries), GoodRx offers an exclusive discount price for Seysara of approximately $175/month — representing an 80%+ reduction from retail. GoodRx has partnered with InsideRx and Almirall to provide this pricing.

Important clinical note: GoodRx and manufacturer copay cards are cash-pay programs — they cannot be used simultaneously with insurance. Counsel patients to compare their insurance copay vs. the GoodRx or savings card price to determine which is lower.

Savings Tool 3: Prior Authorization Strategy

When prescribing Seysara to patients with commercial insurance, initiate prior authorization proactively rather than waiting for a pharmacy rejection. Key documentation elements to strengthen a PA submission:

IGA score or documented acne severity (moderate to severe, non-nodular inflammatory lesions)

Documentation of failure or intolerance to first-line therapies (generic doxycycline, minocycline, or topical antibiotics combined with benzoyl peroxide)

Specific reason for Seysara selection (e.g., narrower spectrum to reduce resistance risk, better GI tolerance profile, avoidance of photosensitivity issues that affected adherence to doxycycline)

Reference the AAD acne guidelines which conditionally recommend Seysara for moderate to severe acne

If a PA is denied, the appeals process can be strengthened by adding peer-reviewed literature supporting Seysara's resistance profile, or by noting the contraindication against doxycycline + isotretinoin if the patient is on both. During the appeals process, the Almirall Advantage savings card can serve as a bridge for commercially insured patients.

Savings Tool 4: Specialty Pharmacy Coordination

Almirall's specialty pharmacy partners offer a valuable service for your patients:

Benefits investigation — the specialty pharmacy verifies the patient's coverage and identifies the lowest cost pathway

Savings card coordination — they apply the copay card as part of the fulfillment process

Home delivery — eliminates the pharmacy stock access problem entirely

Refill adherence support — specialty pharmacies often do proactive outreach for refills, improving adherence

Helping Patients Who Are Not Eligible for Any Savings Programs

For patients on Medicare, Medicaid, or other government programs who can't use the manufacturer savings card or meet GoodRx's needs, realistic alternatives include:

Generic doxycycline: AAD-strongly recommended, costs $10–$30/month at most pharmacies, available everywhere

Generic minocycline: AAD-conditionally recommended, costs $30–$60/month for 60 tablets

Topical antibiotic combinations: Clindamycin + benzoyl peroxide, widely covered by most insurance plans

Practical Workflow: Seysara Prescribing + Savings Integration

Determine patient's insurance status (commercial vs. government program)

Provide Almirall Advantage information to all commercially insured patients at point of prescribing

Initiate prior authorization proactively for plans known to require it

E-prescribe to a pharmacy known to stock Seysara, or refer to specialty pharmacy

For patients with access difficulties, recommend medfinder to locate in-stock pharmacies

For government program patients, discuss cost-effective alternatives or explore state-specific pharmaceutical assistance programs (SPAPs)

medfinder offers a provider-facing tool to help your patients locate medications quickly. Visit medfinder for providers to learn how it can integrate into your patient counseling workflow.